The Applications and Pitfalls of Cone-Beam Computed Tomography-Based Synthetic Computed Tomography for Adaptive Evaluation in Pencil-Beam Scanning Proton Therapy

Author:

Tsai Pingfang1,Tseng Yu-Lun23,Shen Brian1,Ackerman Christopher4,Zhai Huifang A.1,Yu Francis1,Simone Charles B.1ORCID,Choi J. Isabelle1,Lee Nancy Y.5,Kabarriti Rafi6,Lazarev Stanislav7,Johnson Casey L.1ORCID,Liu Jiayi1,Chen Chin-Cheng1ORCID,Lin Haibo1

Affiliation:

1. New York Proton Center, New York, NY 10035, USA

2. Proton Center, Taipei Medical University, Taipei 11031, Taiwan

3. Department of Radiation Oncology, Taipei Medical University, Taipei 11031, Taiwan

4. California Protons Center Therapy Center, San Diego, CA 92121, USA

5. Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA

6. Department of Radiation Oncology, Montefiore Medical Center, Bronx, NY 10467, USA

7. Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA

Abstract

Purpose: The study evaluates the efficacy of cone-beam computed tomography (CBCT)-based synthetic CTs (sCT) as a potential alternative to verification CT (vCT) for enhanced treatment monitoring and early adaptation in proton therapy. Methods: Seven common treatment sites were studied. Two sets of sCT per case were generated: direct-deformed (DD) sCT and image-correction (IC) sCT. The image qualities and dosimetric impact of the sCT were compared to the same-day vCT. Results: The sCT agreed with vCT in regions of homogeneous tissues such as the brain and breast; however, notable discrepancies were observed in the thorax and abdomen. The sCT outliers existed for DD sCT when there was an anatomy change and for IC sCT in low-density regions. The target coverage exhibited less than a 5% variance in most DD and IC sCT cases when compared to vCT. The Dmax of serial organ-at-risk (OAR) in sCT plans shows greater deviation from vCT than small-volume dose metrics (D0.1cc). The parallel OAR volumetric and mean doses remained consistent, with average deviations below 1.5%. Conclusion: The use of sCT enables precise treatment and prompt early adaptation for proton therapy. The quality assurance of sCT is mandatory in the early stage of clinical implementation.

Publisher

MDPI AG

Subject

Cancer Research,Oncology

全球学者库

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"全球学者库"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前全球学者库共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2023 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3